Application 761092

Type
BLA
Sponsor
LEADIANT BIOSCI INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001REVCOVIELAPEGADEMASE-LVLRINJECTABLE;INJECTION1.6MG/MLNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
10122-502Revcovielapegademase-lvlrChiesi USA, Inc.BLACurrent
10122-502Revcovielapegademase-lvlrChiesi USA, Inc.BLACurrent
10122-502Revcovielapegademase-lvlrChiesi USA, Inc.BLACurrent
57665-002Revcovielapegademase-lvlrLeadiant Biosciences, Inc.BLACurrent
57665-002Revcovielapegademase-lvlrLeadiant Biosciences, Inc.BLACurrent
57665-002Revcovielapegademase-lvlrLeadiant Biosciences, Inc.BLACurrent
57665-002Revcovielapegademase-lvlrLeadiant Biosciences, Inc.BLACurrent
57665-002Revcovielapegademase-lvlrLeadiant Biosciences, Inc.BLACurrent
57665-002Revcovielapegademase-lvlrLeadiant Biosciences, Inc.BLACurrent
57665-002Revcovielapegademase-lvlrLeadiant Biosciences, Inc.BLACurrent
57665-002Revcovielapegademase-lvlrLeadiant Biosciences, Inc.BLACurrent
57665-002Revcovielapegademase-lvlrLeadiant Biosciences, Inc.BLACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
65529SUPPL2020-12-08
65514SUPPL2020-12-07
56322ORIG2018-11-07
55936ORIG2018-10-15
55849ORIG2018-10-05